LOGIN
Periprosthetic bone loss post-total hip arthroplasty mitigated by bisphosphonate therapy
February 2019
Periprosthetic bone loss post-total hip arthroplasty mitigated by bisphosphonate therapy
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A
Effects of bisphosphonates in preventing periprosthetic bone loss following total hip arthroplasty: a systematic review and meta-analysis
J Orthop Surg Res. 2018 Sep 4;13(1):225. doi: 10.1186/s13018-018-0918-7Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
12 randomized controlled trials were included in this meta-analysis which sought to evaluate the effect of bisphosphonate therapy in reducing loss of periprosthetic bone mineral density after total hip arthroplasty. In pooled analyses, reduction of periprosthetic bone mineral density was smaller among BP groups compared to control groups within 1 year of surgery, at 2-4 years after surgery, and at...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.